By proceeding, you agree to our Terms of Use and Privacy Policy.
The exploration of novel cell lines to be used in CAR-based therapies has opened many possibilities for future ‘CGT 2.0’ treatments, both allogeneic and autologous. Join us at our new CAR & T Cell Therapies track within BPI West to learn more about these emerging CGT 2.0 cell lines, and the opportunities they hold.
Discover current developments and advances in cell and gene engineering.
Join the summit to understand the current CAR & T Cell therapies track and learn more about emerging CGT 2.0 cell lines and the opportunities they hold.
Gather inputs from industry leaders on current approaches to solve the flaws of CAR, solid tumor obstacles and revolutionizing CGT administration.
Learn more about overcoming solid tumor obstacles by hearing from experts about their approaches to improve the efficacy of developing therapies.
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Event Started
USA
Paid
Boston
We are the world’s leading producer of live events and digital communities, where professionals share knowledge and make connections to help them grow professionally and commercially.
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses.
Cellares is revolutionizing cell therapy manufacturing.
SmartLabs is accelerating the pace of scientific discovery by radically transforming the way the world builds and uses lab space.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.